Hikal Ltd News

Smallcap pharma stock hits 52-week low, slips 8% on Q1 loss. Do you own?

Shares of Hikal hit a 52-week low of ₹281.90, falling 8 per cent on the BSE in Thursday's intra-day trade after the pharma company posted a net loss of ₹22.4 crore in Q1FY26.